Guggenheim Raises Cigna Group (NYSE:CI) Price Target to $338.00

Key Points

• Guggenheim raised its price target to $338 and kept a "buy" rating on Cigna, implying roughly a 19.35% upside
• Cigna beat quarterly expectations with EPS of $7.79 (vs. $7.60 est.) and revenue of $68.52B, set FY2026 EPS guidance around 30.35, and the stock trades near $283.20 with a P/E of ~11.96 and a market cap of ~$74.6B.
• Insiders sold shares in March (notably Everett Neville and Nicole S. Jones), leaving insider ownership at about 0.60%, while institutional investors hold roughly 86.99% of the stock.

Cigna Group (NYSE:CI - Get Free Report) had its price target increased by equities research analysts at Guggenheim from $334.00 to $338.00 in a research note issued to investors on Monday,Benzinga reports. The firm presently has a "buy" rating on the health services provider's stock. Guggenheim's price target suggests a potential upside of 19.35% from the stock's current price.

A number of other research analysts have also recently commented on the company. Truist Financial upped their price objective on Cigna Group from $320.00 to $350.00 and gave the company a "buy" rating in a report on Tuesday, February 17th. UBS Group restated a "buy" rating and issued a $375.00 target price on shares of Cigna Group in a research report on Monday, February 9th. Cantor Fitzgerald upped their price target on Cigna Group from $325.00 to $340.00 and gave the company an "overweight" rating in a research note on Friday. Piper Sandler lowered their price target on Cigna Group from $374.00 to $370.00 and set an "overweight" rating for the company in a report on Tuesday, March 3rd. Finally, Wells Fargo & Company boosted their price objective on shares of Cigna Group from $300.00 to $305.00 and gave the company an "equal weight" rating in a report on Friday. One research analyst has rated the stock with a Strong Buy rating, sixteen have given a Buy rating and four have assigned a Hold rating to the company's stock. Based on data from MarketBeat.com, Cigna Group currently has an average rating of "Moderate Buy" and a consensus price target of $337.70.

Cigna Group Price Performance

Cigna Group stock opened at $283.20 on Monday. The company has a current ratio of 0.73, a quick ratio of 0.73 and a debt-to-equity ratio of 0.69. The company has a 50-day moving average price of $274.34 and a 200 day moving average price of $276.63. Cigna Group has a 12-month low of $239.51 and a 12-month high of $338.89. The stock has a market cap of $74.63 billion, a P/E ratio of 11.96, a PEG ratio of 0.98 and a beta of 0.30.

Cigna Group (NYSE:CI - Get Free Report) last posted its earnings results on Thursday, April 30th. The health services provider reported $7.79 earnings per share for the quarter, beating the consensus estimate of $7.60 by $0.19. Cigna Group had a net margin of 2.26% and a return on equity of 19.75%. The company had revenue of $68.52 billion for the quarter, compared to analyst estimates of $66.29 billion. During the same period in the previous year, the business posted $6.74 EPS. Cigna Group's revenue was up 4.6% on a year-over-year basis. Cigna Group has set its FY 2026 guidance at 30.350- EPS. Sell-side analysts anticipate that Cigna Group will post 30.41 earnings per share for the current year.

Insider Buying and Selling at Cigna Group

In other Cigna Group news, insider Everett Neville sold 1,719 shares of the business's stock in a transaction dated Monday, March 2nd. The shares were sold at an average price of $288.91, for a total transaction of $496,636.29. Following the sale, the insider directly owned 5,670 shares in the company, valued at $1,638,119.70. This represents a 23.26% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Nicole S. Jones sold 2,307 shares of Cigna Group stock in a transaction on Monday, March 2nd. The stock was sold at an average price of $288.91, for a total transaction of $666,515.37. Following the sale, the insider directly owned 32,647 shares of the company's stock, valued at approximately $9,432,044.77. This trade represents a 6.60% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. 0.60% of the stock is currently owned by insiders.

Institutional Investors Weigh In On Cigna Group

Several large investors have recently modified their holdings of the stock. Mirae Asset Global Investments Co. Ltd. lifted its position in shares of Cigna Group by 11.7% in the third quarter. Mirae Asset Global Investments Co. Ltd. now owns 45,235 shares of the health services provider's stock valued at $13,039,000 after acquiring an additional 4,738 shares in the last quarter. Maj Invest Holding A S lifted its holdings in shares of Cigna Group by 2.4% during the 3rd quarter. Maj Invest Holding A S now owns 422,728 shares of the health services provider's stock valued at $121,854,000 after acquiring an additional 10,042 shares in the last quarter. Providence Capital Advisors LLC boosted its holdings in Cigna Group by 1,016.8% in the 3rd quarter. Providence Capital Advisors LLC now owns 8,510 shares of the health services provider's stock worth $2,453,000 after acquiring an additional 7,748 shares during the period. National Pension Service lifted its stake in shares of Cigna Group by 3.2% in the third quarter. National Pension Service now owns 683,751 shares of the health services provider's stock worth $197,091,000 after acquiring an additional 21,203 shares in the last quarter. Finally, Banco Bilbao Vizcaya Argentaria S.A. boosted its stake in Cigna Group by 13.5% during the 3rd quarter. Banco Bilbao Vizcaya Argentaria S.A. now owns 34,114 shares of the health services provider's stock valued at $9,839,000 after acquiring an additional 4,066 shares during the last quarter. Hedge funds and other institutional investors own 86.99% of the company's stock.

Cigna Group Company Profile

Cigna Group NYSE: CI is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.